Multinationals are now laying off or plan to let go of their workers globally amid a sluggish global economy

Multinationals laying off employees in China, elsewhere

Staff Reporter

2013-12-30

International firms are now laying off or plan to let go of their workers globally amid a sluggish global economy, according to the Beijing-based Economic Observer. A man, 52, going under the pseudonym Wang Jie, was one of the first employees at his multinational telecommunications equipment company to be let go two weeks ago. He understood the difficult situation his company was facing, but was still unable to accept the fact that he was fired after having worked with the firm since 1996.Motorola slashed at least 700 from its workforce in China in 2012. Nokia plans to reduce its staff by about 10,000 by the end of 2013. It had laid off 40,000 employees two years ago, which was nearly half of its total staff strength.

Since June this year, IBM has let go of 6,000 to 8,000 workers at its companies around the world.

Some employees at IBM China’s hardware department have also been affected. A person working with Hewlett-Packard’s China division for many years was called into a meeting on Nov. 18, 2013 and told that his job contract would be terminated 20 minutes later.

The company’s statistics showed that HP had terminated 17,800 workers in 2012 and planned on letting go of a total of 29,000 by the end of 2014.

It is not easy for these older Chinese workers to start a new career after leaving a company at which they have worked for years.

The report stated that multinational companies found Chinese workers to be inflexible, as these workers were unable to fully learn the entire process from planning to execution.

“In multinational firms, a worker merely knows how to do one thing and he or she cannot demonstrate his or her value at a certain level, which might be the major risk that most multinational companies face,” a technician who left IBM to join a Chinese state-owned firm said.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment